{"text_format":"1","workbook":"xlsx","n_sheets":12,"sheets":["Summary of scores (2)","Introduction","Instructions","FAQs","Guidance for PrEP","Programme Management","Programme Implementation","Programme Outcomes ","Summary of scores","Next steps","Bibliography","Acronyms"],"not_rendered":{"charts":6,"images":1,"macros":1,"external_links":0,"defined_names":28,"comments":1,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"Summary of scores (2)","index":0,"n_rows":142,"n_cols":6,"rows_kept":142,"cut":false,"hidden":true,"merged":[[74,3,75,3],[2,2,67,2],[2,3,23,3],[24,3,45,3],[46,3,67,3],[109,2,141,2],[109,3,136,3],[137,3,141,3],[1,2,1,6],[68,2,74,2],[68,3,71,3],[72,3,73,3],[76,2,108,2],[93,3,97,3],[99,3,100,3],[101,3,108,3],[76,3,79,3],[80,3,82,3],[83,3,86,3],[87,3,89,3],[90,3,92,3]]}
[]
[null,null,"Summary of scores"]
[null,null,"Prevention\nPackages","AGYW Prevention Package\n(HIGH Incidence Locations)",null,"Risk Assessment / Profiling"]
[null,null,null,null,null,"Male and female condoms and lubricants "]
[null,null,null,null,null,"HIV testing, treatment, counselling and support"]
[null,null,null,null,null,"Pre-exposure Prophylaxis"]
[null,null,null,null,null,"STI diagnosis & service integration"]
[null,null,null,null,null,"SRH services incl. contraceptive mix"]
[null,null,null,null,null,"GBV services, post-rape care "]
[null,null,null,null,null,"Antenatal care (ANC) including PMTCT"]
[null,null,null,null,null,"Clinical service package for sex partners of AGYW"]
[null,null,null,null,null,"Accessible services"]
[null,null,null,null,null,"Youth-friendly/Acceptable services"]
[null,null,null,null,null,"Sensitisation"]
[null,null,null,null,null,"School-based prevention campaigns"]
[null,null,null,null,null,"Comprehensive sexuality education"]
[null,null,null,null,null,"Keeping girls in school"]
[null,null,null,null,null,"Community Mobilisation & demand generation"]
[null,null,null,null,null,"Increasing access to justice (policy and legal) "]
[null,null,null,null,null,"Gender-based violence prevention and management "]
[null,null,null,null,null,"Social protection & Social Asset Building"]
[null,null,null,null,null,"Economic Empowerment & Incentives"]
[null,null,null,null,null,"Increasing access to education for young women "]
[null,null,null,null,null,"Transforming harmful cultural and gender norms through community platforms"]
[null,null,null,"AGYW Prevention Package\n(VERY HIGH Incidence Locations)",null,"Risk Assessment / Profiling"]
[null,null,null,null,null,"Male and female condoms and lubricants "]
[null,null,null,null,null,"HIV testing, treatment, counselling and support"]
[null,null,null,null,null,"Pre-exposure Prophylaxis"]
[null,null,null,null,null,"STI diagnosis & service integration"]
[null,null,null,null,null,"SRH services incl. contraceptive mix"]
[null,null,null,null,null,"GBV services, post-rape care "]
[null,null,null,null,null,"Antenatal care (ANC) including PMTCT"]
[null,null,null,null,null,"Clinical service package for sex partners of AGYW"]
[null,null,null,null,null,"Accessible services"]
[null,null,null,null,null,"Youth-friendly/Acceptable services"]
[null,null,null,null,null,"Sensitisation"]
[null,null,null,null,null,"School-based prevention campaigns"]
[null,null,null,null,null,"Comprehensive sexuality education"]
[null,null,null,null,null,"Keeping girls in school"]
[null,null,null,null,null,"Community Mobilisation & demand generation"]
[null,null,null,null,null,"Increasing access to justice (policy and legal) "]
[null,null,null,null,null,"Gender-based violence prevention and management "]
[null,null,null,null,null,"Social protection & Social Asset Building"]
[null,null,null,null,null,"Economic Empowerment & Incentives"]
[null,null,null,null,null,"Increasing access to education for young women "]
[null,null,null,null,null,"Transforming harmful cultural and gender norms through community platforms"]
[null,null,null,"AGYW Prevention Package\n(EXTREMELY HIGH Incidence Locations)",null,"Risk Assessment / Profiling"]
[null,null,null,null,null,"Male and female condoms and lubricants "]
[null,null,null,null,null,"HIV testing, treatment, counselling and support"]
[null,null,null,null,null,"Pre-exposure Prophylaxis"]
[null,null,null,null,null,"STI diagnosis & service integration"]
[null,null,null,null,null,"SRH services incl. contraceptive mix"]
[null,null,null,null,null,"GBV services, post-rape care "]
[null,null,null,null,null,"Antenatal care (ANC) including PMTCT"]
[null,null,null,null,null,"Clinical service package for sex partners of AGYW"]
[null,null,null,null,null,"Accessible services"]
[null,null,null,null,null,"Youth-friendly/Acceptable services"]
[null,null,null,null,null,"Sensitisation"]
[null,null,null,null,null,"School-based prevention campaigns"]
[null,null,null,null,null,"Comprehensive sexuality education"]
[null,null,null,null,null,"Keeping girls in school"]
[null,null,null,null,null,"Community Mobilisation & demand generation"]
[null,null,null,null,null,"Increasing access to justice (policy and legal) "]
[null,null,null,null,null,"Gender-based violence prevention and management "]
[null,null,null,null,null,"Social protection & Social Asset Building"]
[null,null,null,null,null,"Economic Empowerment & Incentives"]
[null,null,null,null,null,"Increasing access to education for young women "]
[null,null,null,null,null,"Transforming harmful cultural and gender norms through community platforms"]
[null,null,"Programme Management","1. Leadership & coordination",null,"National Strategy and Strategic Plan"]
[null,null,null,null,null,"National Technical working group (TWG) for AGYW/Youth Prevention"]
[null,null,null,null,null,"Accountability"]
[null,null,null,null,null,"National and Sub-National plans"]
[null,null,null,"2. Strategy, Policy & regulation",null,"Policies"]
[null,null,null,null,null,"Guidelines"]
[null,null,null,"3. Financing",null,"Costing"]
[null,null,null,null,null,"Budget planning"]
[null,null,"Programme Implementation","4. Step One: Targeting & planning",null,"Demographic assessment & disaggregation"]
[null,null,null,null,null,"Needs assessment"]
[null,null,null,null,null,"Characterisation of male partners of AGYW"]
[null,null,null,null,null,"Target setting"]
[null,null,null,"5. Step Two: Population size estimation by HIV Incidence Level",null,"AGYW PSE - high incidence settings"]
[null,null,null,null,null,"AGYW PSE - very high incidence settings"]
[null,null,null,null,null,"AGYW PSE - extremely incidence settings"]
[null,null,null,"6. Step Three: Identify the groups \"most vulnerable\" or \"most in need\"",null,"Epidemiological assessment (sero-prevalence survey & determinants of risk)"]
[null,null,null,null,null,"Behavoural risk factors"]
[null,null,null,null,null,"Biological risk factors"]
[null,null,null,null,null,"Structural risk factors"]
[null,null,null,"7. Step Four: Review available programme elements and their coverage",null,"Health sector platforms (facilities, service delivery points)"]
[null,null,null,null,null,"Education platforms (schools, universities)"]
[null,null,null,null,null,"Community platforms (NGOs, CSOs)"]
[null,null,null,"8. Step Five: Develop a Results Framework (Theory of Change)",null,"Define & prioritise HIV prevention packages per applicable incidence category"]
[null,null,null,null,null,"Include Programmatic coverage targets"]
[null,null,null,null,null,"Include Cross-cutting activities & complementary action"]
[null,null,null,"9. Step Six: Define/Develop Delivery Systems",null,"Develop/ensure health platforms"]
[null,null,null,null,null,"Develop/ensure education platforms"]
[null,null,null,null,null,"Develop/ensure Community platforms"]
[null,null,null,null,null,"Peer outreach educators (POE), Peer testers and Community Health Workers (CHWs)"]
[null,null,null,null,null,"Meaningful engagement of affected communities in leadership & coordination"]
[null,null,null,"10. Step Seven: Define Management Mechanism",null,"National & Sub National Management systems"]
[null,null,null,"11. Step Eight: Develop Costed Operational Plan",null,"Operational plan"]
[null,null,null,null,null,"Available Resources"]
[null,null,null,"12. Step Nine: Develop M&E Plan",null,"Routine monitoring"]
[null,null,null,null,null,"Referral system tracking"]
[null,null,null,null,null,"Quality assessment"]
[null,null,null,null,null,"Surveillance "]
[null,null,null,null,null,"Data flow"]
[null,null,null,null,null,"Data for decision making"]
[null,null,null,null,null,"The use of Unique Identifier Code for program monitoring"]
[null,null,null,null,null,"Budget monitoring"]
[null,null,"Programme Outcomes","13. Outcomes for AGYW Prevention",null,"Number of new HIV infections per 1000 uninfected population"]
[null,null,null,null,null,"Number and % of people living with HIV "]
[null,null,null,null,null,"Number of AIDS related deaths per 100,000 population"]
[null,null,null,null,null,"Percentage of (estimated) people living with HIV who have been tested HIV-positive"]
[null,null,null,null,null,"Percentage of adults and children with HIV, known to be on treatment 12 months after initiation of antiretroviral therapy"]
[null,null,null,null,null,"Percentage of people living with HIV and on ART who are virologically suppressed"]
[null,null,null,null,null,"Percentage of ever-married or partnered women aged 15-49 who experienced physical or sexual violence from a male intimate partner in the past 12 months"]
[null,null,null,null,null,"Percentage of sexually active young women age 15 - 24 who had multiple sexual partners."]
[null,null,null,null,null,"Percentage of sexually active men age 15-49 who had multiple sexual partners."]
[null,null,null,null,null,"Knows a formal source for condoms (young women 15-24)"]
[null,null,null,null,null,"Knows a formal source for condoms (young men 15-24)"]
[null,null,null,null,null,"Condom use with non-regular partners (young women, 15-24)"]
[null,null,null,null,null,"Condom use with non regular partners (young men, 15-24)"]
[null,null,null,null,null,"Percentage of females age 15-24 who report unintended pregnancy of of current pregnancy or most recent births (teen pregnancy)"]
[null,null,null,null,null,"Percentage of youth neither in employment nor in education or training (NEET)"]
[null,null,null,null,null,"Percentage of females aged 15 - 24 who dropped out of school in the last year"]
[null,null,null,null,null,"Percentage of young people aged 10–24 years reached by life skills–based HIV education in schools"]
[null,null,null,null,null,"Percentage of priority districts (administrative areas) with dedicated programs for young women & male partners (full package) "]
[null,null,null,null,null,"Percentage of adolescent girls and young women in high-HIV incidence communities reached with two interventions in the past three months"]
[null,null,null,null,null,"Percentage of adolescent girls and young women (AGYW) who received PEP"]
[null,null,null,null,null,"PrEP Indicator - tbc"]
[null,null,null,null,null,"SRHR access indicator(s) - tbc"]
[null,null,null,null,null,"Number of AGYW who received GBV related services (e.g. referral for legal or medical care e.g. PEP, post violence care & support services)"]
[null,null,null,null,null,"Percentage of AGYW who received livelihood support (cash transfer or other economic empowerment approaches)"]
[null,null,null,null,null,"Percentage of AGYW who reached with \"keeping girls in school\" initiatives (including education subsidy and others)"]
[null,null,null,null,null,"Number of medical male circumcisions performed according to national standards"]
[null,null,null,null,null,"Percentage of people living with HIV that initiated ART with a CD4 count of <200 cells/mm3"]
[null,null,null,null,null,"Percentage of people living with HIV and on antiretroviral therapy who have a suppressed viral load at 12 months (<1000 copies/ml)"]
[null,null,null,"14. Sustainability",null,"Resource mobilisation and financing"]
[null,null,null,null,null,"Domestic resourcing"]
[null,null,null,null,null,"Social contracting"]
[null,null,null,null,null,"Capacity building and TA Plan"]
[null,null,null,null,null,"Sustainability plan and transition roadmap"]

{"sheet":"Introduction","index":1,"n_rows":2,"n_cols":3,"rows_kept":2,"cut":false,"hidden":false,"merged":[[1,2,1,22]]}
[]
[null,null,"What are the HIV Prevention Self-Assessment Tools (PSAT)?"]

{"sheet":"Instructions","index":2,"n_rows":57,"n_cols":19,"rows_kept":57,"cut":false,"hidden":false,"merged":[[2,2,2,17]]}
[]
[]
[null,null,"How to complete the Prevention Self Assessment Tool (PSAT)"]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[]
[null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,null,"I"]

{"sheet":"FAQs","index":3,"n_rows":2,"n_cols":3,"rows_kept":2,"cut":false,"hidden":false,"merged":[[1,2,1,22]]}
[]
[null,null,"Frequently Asked Questions"]

{"sheet":"Guidance for PrEP","index":4,"n_rows":2,"n_cols":3,"rows_kept":2,"cut":false,"hidden":false,"merged":[[1,2,1,22]]}
[]
[null,null,"Offering Pre Exposure Prophylaxis"]

{"sheet":"Programme Management","index":5,"n_rows":48,"n_cols":16,"rows_kept":48,"cut":false,"hidden":false,"merged":[[1,2,1,9],[3,3,3,4],[4,2,4,10],[6,9,10,9],[11,9,19,9],[5,2,10,2],[11,2,19,2],[20,2,22,2],[33,2,33,10],[34,2,42,2],[20,9,22,9],[24,9,26,9],[27,9,32,9],[34,9,42,9],[24,2,26,2],[27,2,32,2],[23,2,23,10]]}
[]
[null,null,"Programme Management"]
[]
[null,null,"Element","Criteria",null,"N/A","Absent","Present but not optimal","Present and working well","Average for element","Comments (if applicable)","Absent","Present","Optimal","Average","Sustainability Single Figure"]
[null,null,"Strategy, Policy, and Regulation"]
[null,null,"National HIV Prevention Strategy","○","PrEP as part of comprehensive HIV prevention in National HIV Strategy",null,null,null,null,null,null,{"$f":"IF(ISBLANK(G6),0,1)","v":0},{"$f":"IF(ISBLANK(H6),0,3)","v":0},{"$f":"IF(ISBLANK(I6),0,5)","v":0},{"$f":"IFERROR(ROUND(AVERAGEIF(L6:N11,\"<>0\",L6:N11),0),\"-\")","v":"-"}]
[null,null,null,"○","Oral PrEP and long-acting PrEP (i.e. DVR and injectables) are included as part of comprehensive HIV prevention in National HIV Strategy",null,null,null,null,{"$f":"IFERROR(O6,\"-\")","v":"-"},null,{"$f":"IF(ISBLANK(G7),0,1)","v":0},{"$f":"IF(ISBLANK(H7),0,3)","v":0},{"$f":"IF(ISBLANK(I7),0,5)","v":0}]
[null,null,null,"○","There is sufficient detail to guide implementation of PrEP programs",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Vision for PrEP roll out based on WHO guidance or in-country experience",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP program integrated into routine health system",null,null,null,null,null,null,0,0,0,null,{"$f":"IF(MAX(L10:N10)=0,\"\",MAX(L10:N10))","v":""}]
[null,null,null,"○","PrEP is available for all those at substantial risk   ",null,null,null,null,null,null,0,0,0]
[null,null,"National Clinical Guidelines","○","National PrEP clinical guidelines are in place OR PrEP guidance is included in National ARV Guidelines ",null,null,null,null,{"$f":"IFERROR(O12,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L12:N20,\"<>0\",L12:N20),0),\"-\")","v":"-"}]
[null,null,null,"○","There is sufficient detail to direct PrEP providers in one or more of the following areas: eligibility screening and initiation, laboratory testing, monitoring schedule, counselling",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Guidelines have approval or buy-in from provider associations",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Guidelines include guidance on who can provide PrEP and required training",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Guidelines informed by WHO guidelines and in-country experience ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Applicable and available to all PrEP providers (public and private)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Guidelines include promotion of clinical follow up for people who purchase PrEP online",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Guidelines include daily oral PrEP, event-driven PrEP, and long acting PrEP methods (i.e. DVR, injectables)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","COVID-19 infection prevention and control measures are incorporated into all HIV prevention/PrEP strategies, plans and guidelines",null,null,null,null,null,null,0,0,0]
[null,null,"PrEP Drug regulatory status","○","Regulatory approval of more than one product (including generic ART) for preventative use exists OR waivers in place",null,null,null,null,{"$f":"IFERROR(O21,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L21:N23,\"<>0\",L21:N23),0),\"-\")","v":"-"}]
[null,null,null,"○","Competitive tender between approved products has been issued",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP modalities are included in the essential medicines list (EML)",null,null,null,null,null,null,0,0,0]
[null,null,"Leadership and Coordination",null,null,null,null,null,null,{"$f":"IFERROR(O25,\"-\")","v":"-"}]
[null,null,"Leadership and Accountability","○","PrEP focal person has substantial leadership and authority within national government",null,null,null,null,{"$f":"IFERROR(O25,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L25:N27,\"<>0\",L25:N27),0),\"-\")","v":"-"}]
[null,null,null,"○","PrEP focal person provides leadership and oversight for overall national PrEP program implementation and monitoring",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Donor-funded implementers report regularly to the government PrEP focal person",null,null,null,null,null,null,0,0,0]
[null,null,"Stakeholder Engagement","○","All actors involved in PrEP implementation have clear roles and responsibilities",null,null,null,null,{"$f":"IFERROR(O28,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L28:N33,\"<>0\",L28:N33),0),\"-\")","v":"-"}]
[null,null,null,"○","Civil society is engaged in key decisions",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP end users are engaged in key decisions, including explicit involvement of members of relevant KP groups (e.g. MSM, FSW, youth)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","A technical working group with a clear Terms of Reference (ToR) provides country level coordination",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","TWG includes representation of national AIDS councils, drug manufacturers, drug regulatory council, professional associations (i.e. physicians councils), local implementers (i.e. subnational departments of health), donors, international organizations, and civil society",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Multisectoral coordination with other ministries/departments (e.g. finance, law enforcement, education, development, etc.) takes place",null,null,null,null,null,null,0,0,0]
[null,null,"Financing",null,null,null,null,null,null,null,null,0,0,0]
[null,null,"Budget","○","National PrEP budget in place",null,null,null,null,{"$f":"IFERROR(O35,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L35:N43,\"<>0\",L35:N43),0),\"-\")","v":"-"}]
[null,null,null,"○","Costing exercise has been conducted, which realistically estimates budget for all components of PrEP package (PrEP modalities - drug, ring, injectable; lab tests; Human Resources; communication strategy; M&E system; etc.) ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP budget (including testing, communication, training) is integrated into overall budget for relevant activity",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Domestic funding is available and allocated for a relevant proportion of program, donors committed to filling gaps as required",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Funding bodies / partners are coordinated",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Subnational level budgets are in place ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Budget gaps are identified and plans have been put in place to fill the gaps",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Relevant proportion of PrEP program is financed domestically (minimum >10%):",null,null,null,null,null,null,0,0,0,null,{"$f":"IF(MAX(L42:N42)=0,\"\",MAX(L42:N42))","v":""}]
[null,null,null,"○","Policy in place that allows for PrEP program to be financed domestically on continuous basis",null,null,null,null,null,null,0,0,0,null,{"$f":"IF(MAX(L43:N43)=0,\"\",MAX(L43:N43))","v":""}]
[]
[]
[null,null,null,null,null,null,null,null,null,null,null,null,{"$f":"COUNTIF(O6:O43,\"-\")","v":6}]
[null,null,null,null,null,null,null,null,null,null,null,null,{"$f":"COUNTIF(O6:O43,\">0\")","v":0}]
[null,null,null,null,null,null,null,null,null,null,null,"Sheet Completion",{"$f":"M47/(M46+M47)","v":0},{"$f":"1-M48","v":1}]

{"sheet":"Programme Implementation","index":6,"n_rows":157,"n_cols":16,"rows_kept":157,"cut":false,"hidden":false,"merged":[[119,9,127,9],[128,9,138,9],[139,9,144,9],[145,9,152,9],[17,2,25,2],[80,9,90,9],[91,9,99,9],[100,9,109,9],[110,9,115,9],[116,9,117,9],[139,2,144,2],[145,2,152,2],[128,2,138,2],[39,9,43,9],[44,9,51,9],[53,9,56,9],[12,9,16,9],[17,9,25,9],[26,9,33,9],[35,9,38,9],[5,9,11,9],[57,9,62,9],[63,9,66,9],[67,9,69,9],[71,9,76,9],[91,2,99,2],[57,2,62,2],[63,2,66,2],[77,9,79,9],[100,2,109,2],[110,2,115,2],[116,2,117,2],[119,2,127,2],[1,2,1,7],[67,2,69,2],[71,2,76,2],[77,2,79,2],[80,2,90,2],[5,2,11,2],[12,2,16,2],[26,2,33,2],[35,2,38,2],[39,2,43,2],[44,2,51,2],[53,2,56,2]]}
[]
[]
[]
[null,null,"Element","Criteria",null,"N/A","Absent","Present but not optimal","Present and working well","Average for element","Comments (if applicable)","Absent","Present","Optimal","Average","Sustainability Single Figure"]
[null,null,"Targeting and Planning"]
[null,null,"Implementation Work Plans",null,"Policy and Work plans",null,null,null,null,{"$f":"IFERROR(O6,\"-\")","v":"-"},null,null,null,null,{"$f":"IFERROR(ROUND(AVERAGEIF(L7:N12,\"<>0\",L7:N12),0),\"-\")","v":"-"}]
[null,null,null,"○","National and subnational level work plans are in place",null,null,null,null,null,null,{"$f":"IF(ISBLANK(G7),0,1)","v":0},{"$f":"IF(ISBLANK(H7),0,3)","v":0},{"$f":"IF(ISBLANK(I7),0,5)","v":0}]
[null,null,null,"○","Target populations are involved in the development of the workplans",null,null,null,null,null,null,{"$f":"IF(ISBLANK(G8),0,1)","v":0},{"$f":"IF(ISBLANK(H8),0,3)","v":0},{"$f":"IF(ISBLANK(I8),0,5)","v":0}]
[null,null,null,"○","There is clear delegation of responsibilities and reporting lines",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Timelines and reporting mechanisms are in place",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Review and monitoring mechanisms are in place",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Actions and programme elements have clear link to budget lines",null,null,null,null,null,null,0,0,0]
[null,null,"Assessment of Population at Risk","○","Priority populations are determined by HIV epidemic profile, HIV incidence, prevalence, and geographic distribution of risk",null,null,null,null,{"$f":"IFERROR(O13,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L13:N17,\"<>0\",L13:N17),0),\"-\")","v":"-"}]
[null,null,null,"○","Involvement of priority and key population group members in assessment of populations at risk             ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Assessment of where and how to scale up rollout is done using globally available tools (e.g. OPTIONS Plan4PrEP Toolkit, PrEP-It, WHO Implementation Toolkit for PrEP)        ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Approach is non-stigmatizing - public facing documents refer to high risk behaviours and do not name key populations         ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","At the subnational level data is disaggregated by gender, key population, and age (with smaller age bands for younger populations i.e. 15-19., 20-24, 25-29, etc)",null,null,null,null,null,null,0,0,0]
[null,null," Indicator Targets","○","Targets for programme outcome indicators have been set at national and subnational levels",null,null,null,null,{"$f":"IFERROR(O18,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L18:N26,\"<>0\",L18:N26),0),\"-\")","v":"-"}]
[null,null,null,"○","Targets are based on national and subnational HIV incidence and prevalence and assessment of population at risk",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Targets are informed by in-country implementation data (e.g. demonstration studies if applicable)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Targets are disaggregated by gender, key population, and age (with smaller age bands for younger populations i.e. 15-19., 20-24, 25-29, etc)       ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Timelines for target achievement are in place",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Targets are linked to budget and funding sources              ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Program target setting, forecasting and costing conducting using evidence-based methods and tools e.g. PrEP-it 2.0",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Indicators and targets are in line with international standards (President's Emergency Plan For AIDS Relief (PEPFAR), WHO guidelines)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP Monitoring & Evaluation guidance document available for reference",null,null,null,null,null,null,0,0,0]
[null,null,"Communication Strategy","○","Comprehensive communication strategy in place",null,null,null,null,"-",null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L27:N34,\"<>0\",L27:N34),0),\"-\")","v":"-"}]
[null,null,null,"○","Involvement of priority and key population group members in the development of the communication strategy and demand creation materials",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Communication strategy includes BOTH 1) basic education and awareness of PrEP for general population and 2) demand creation strategy for individuals at higher risk, including information, education, communication materials",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Approach is inclusive and non-stigmatizing",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Multiple channels engaged to mobilize for PrEP (mass media, social media, peer education)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Demand creation messages are differentiated for priority populations and are non-stigmatizing and sensitive     ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Communication strategy around PrEP is part of broader sexual health promotion communication strategy",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Communications materials are pilot tested",null,null,null,null,null,null,0,0,0]
[null,null,"Supply"]
[null,null,"Quantification of Commodities Needed","○","Supply and demand forecasting is based on populations at risk and targets, and considers expected programme growth",null,null,null,null,"-",null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L36:N39,\"<>0\",L36:N39),0),\"-\")","v":"-"}]
[null,null,null,"○","Includes all essential clinical components of the PrEP programme, as well as PrEP adjacent supplies (PrEP modalities - drug, ring, injectable;  HIV tests, CrCl tests, HBV tests, other STI tests, FP supplies, incl. condoms, other) ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Informed by in-country project utilization data (if applicable)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","As programme matures, utilization data feeds into quantification",null,null,null,null,null,null,0,0,0]
[null,null,"Commodity Procurement Plan","○","Manufacturer contract to purchase / supply essential components of PrEP clinical service package in place",null,null,null,null,"-",null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L40:N44,\"<>0\",L40:N44),0),\"-\")","v":"-"}]
[null,null,null,"○","Procurement of supply is reliable and adequate to meet current consumption, with margin to account for growing demand",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Procurement plan is linked with budget and funding sources ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Procurement plan is multiyear",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Commodity procurement is through competitive tender",null,null,null,null,null,null,0,0,0]
[null,null,"Supply chain / LMIS \n(logistics management and information system)","○","Supply of essential components of PrEP clinical service package and adjacent supplies is uninterrupted",null,null,null,null,"-",null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L45:N52,\"<>0\",L45:N52),0),\"-\")","v":"-"}]
[null,null,null,"○","Utilizes existing distribution chain",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Good distribution practices are observed ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Inventory is well managed, no stockouts, expiring drugs appropriately managed",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Commodities reach all facilities providing PrEP (even if not providing ART)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Quality assurance mechanisms are in place",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Volume of PrEP products dispensed per population group is used to monitor coverage",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","LMIS provides accurate picture of status of PrEP package commodities in country (this is periodically evaluated)",null,null,null,null,null,null,0,0,0]
[null,null,"Service Delivery",null,null,null,null,null,null,null,null,null,null,0]
[null,null,"Differentiated","○","PrEP services are available in facilities (facility readiness assessment conducted in all facilities providing PrEP) ",null,null,null,null,"-",null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L54:N57,\"<>0\",L54:N57),0),\"-\")","v":"-"}]
[null,null,null,"○","PrEP services are available out-of-facility (i.e. mobile/outreach services)            ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP services are available through community-led mechanisms (i.e. social contracts, civil society)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP services include peer PrEP delivery",null,null,null,null,null,null,0,0,0]
[null,null,"Integrated","○","Linkage to preventive options (including PrEP) at all HIV testing points",null,null,null,null,"-",null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L58:N63,\"<>0\",L58:N63),0),\"-\")","v":"-"}]
[null,null,null,"○","PrEP available for clients accessing Ante-Natal Care (ANC) and Post Natal Care (PNC) services",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP available to clients accessing Sexual Reproductive Health (SRH) and Family Planning (FP) services",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP available to clients seeking STI testing",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP available at outpatient service points",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP available to partners of clients accessing HIV services",null,null,null,null,null,null,0,0,0]
[null,null,"Accessible","○","Facilities providing PrEP services offer extended operating hours (after hours and weekends)",null,null,null,null,"-",null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L64:N67,\"<>0\",L64:N67),0),\"-\")","v":"-"}]
[null,null,null,"○","Facilities providing PrEP services offer Youth friendly services",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Facilities providing PrEP services are conveniently located geographically",null,null,null,null,null,null,{"$f":"IF(ISBLANK(G66),0,1)","v":0},{"$f":"IF(ISBLANK(H66),0,3)","v":0},{"$f":"IF(ISBLANK(I66),0,5)","v":0}]
[null,null,null,"○","Facilities providing PrEP services welcome clients who order PrEP online",null,null,null,null,null,null,0,0,0]
[null,null,"Acceptable","○","Unique needs of  populations accessing PrEP, which may include KPs and youth are adequately addressed / accommodated ",null,null,null,null,"-",null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L68:N70,\"<>0\",L68:N70),0),\"-\")","v":"-"}]
[null,null,null,"○","PrEP provision is non-judgemental and non-stigmatizing",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP provision is confidential and guarantees anonymity",null,null,null,null,null,null,0,0,0]
[null,null,"Service Delivery Support",null,null,null,null,null,null,null,null,0,0,0]
[null,null,"Training","○","PrEP is included in core training package for all health care workers",null,null,null,null,"-",null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L72:N77,\"<>0\",L72:N77),0),\"-\")","v":"-"}]
[null,null,null,"○","PrEP Managers and providers trained on non-judgemental and non-biased PrEP service provision",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP Managers and providers receive effective position specific training and ongoing mentoring and support",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP Managers and providers trained on reporting tools, timelines, and indicator definitions",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP Managers and providers trained on adverse event monitoring and reporting mechanisms",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Provider training is evaluated and trainers are provided feedback",null,null,null,null,null,null,0,0,0]
[null,null,"Service Delivery Tools","○","Job aids, initiation and monitoring algorithms, and guidance counselling tools developed in accordance with national policy and guidelines",null,null,null,null,{"$f":"IFERROR(O78,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L78:N80,\"<>0\",L78:N80),0),\"-\")","v":"-"}]
[null,null,null,"○","Tools take into consideration unique needs of differing populations",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Tools are available and utilised wherever PrEP services are provided",null,null,null,null,null,null,0,0,0]
[null,null,"Eligibility and initiation testing","○","A variety of HIV testing options are available (facility based, self testing, outreach, etc.)",null,null,null,null,{"$f":"IFERROR(O81,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L81:N91,\"<>0\",L81:N91),0),\"-\")","v":"-"}]
[null,null,null,"○","Direct links from HIV testing services to prevention services (including PrEP services) are in place",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","An individual's HIV risk assessment is a nuanced conversation with the provider - considers individual \"season of risk\", is behaviour oriented, is not based on target populations, and discusses a combination of risk reduction methods               includes likely future behaviour",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","All methods of available PrEP prevention options (oral PrEP, ring, injectables) are discussed",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","An Individual readiness assessment is implemented prior to initiation of the selected PrEP methodology",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Acute HIV infection (AHI) screening conducted, which may include viral load (VL) testing for clients with symptoms (clear guidance is available if VL is not available)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Hepatitis testing, vaccination, or treatment provided according to national guidelines (HBV, HCV)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Syphilis and other STI testing is provided",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","For oral PrEP provision - Renal function evaluated with creatinine clearance test (CrCl). Delayed results are not a barrier to initiation",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Proper PrEP use, including effective use, safe starting and stopping, time needed for protection, event driven protection (specifically for oral PrEP and men who have sex with men (MSM)),  and possible side effects explained to client",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Same-day initiation is available",null,null,null,null,null,null,0,0,0]
[null,null,"Clinical follow-up","○","HIV retesting at month 1",null,null,null,null,{"$f":"IFERROR(O92,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L92:N100,\"<>0\",L92:N100),0),\"-\")","v":"-"}]
[null,null,null,"○","Subsequent follow-up and HIV testing at 3 months (HIV self-testing with clinic validation is an option)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Ongoing risk assessment done",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","SAE (serious adverse events) and side effects monitoring",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Syphilis and other STI testing is provided",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Procedures for periodic drug level testing are in place",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP packaging is acceptable to users ( i.e. discreet, youth friendly )",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Multi-month prescribing or multi-month dispensing is available                   ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Clients who do not return for follow-up appointments are contacted",null,null,null,null,null,null,0,0,0]
[null,null,"Counselling and effective use adherence support report","○","Nuanced and individualized counselling is provided    ",null,null,null,null,{"$f":"IFERROR(O101,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L101:N110,\"<>0\",L101:N110),0),\"-\")","v":"-"}]
[null,null,null,"○","The effective use of PrEP is evaluated and part of discussion of ongoing risk",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Community based /peer counselling support available (e.g. expert clients, peer support groups) ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","IEC materials available",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Counselling includes: Efficacy of chosen method; required use - daily dosing (oral PrEP), monthly or multi-monthly (long acting methods); what to do if dose is missed, ring falls out",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Counselling includes: Seasons of risk",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Counselling includes: The importance of ongoing monitoring while on PrEP",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Counselling includes: Side-effects and side-effects management",null,null,null,null,null,null,0,0,0]
[null,null,null,null,"Counselling includes: Continuation support",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Counselling includes: How to safely discontinue and restart PrEP",null,null,null,null,null,null,0,0,0]
[null,null,"PrEP adjacent package","○","STI testing (syphilis, chlamydia, gonorrhoea) done routinely (concurrently with PrEP visits)",null,null,null,null,{"$f":"IFERROR(O111,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L111:N116,\"<>0\",L111:N116),0),\"-\")","v":"-"}]
[null,null,null,"○","Pregnancy testing and family planning options provided (condoms, oral contraceptive pill, injections, implant etc.)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Link to VMMC as applicable and acceptable",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Harm reduction strategies in place for people who use drugs (needle exchange, methadone available as needed)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Discussion of risk, HIV prevention, and PrEP with clients not seeking HIV services (ANC, PNC, SRH, etc.)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Partner services provided",null,null,null,null,null,null,0,0,0]
[null,null,"COVID-19","○","Programs  are in place to encourage and track COVID-19 vaccine uptake among PrEP users",null,null,null,null,{"$f":"IFERROR(O117,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L117:N118,\"<>0\",L117:M118),0),\"-\")","v":"-"}]
[null,null,null,"○","Continued messaging and safe access to non-facility-based service delivery models (e.g. community-based, home-based, telehealth) during COVID-19 peaks to avoid service disruption",null,null,null,null,null,null,0,0,0]
[null,null,"Programme Monitoring"]
[null,null,"PrEP M&E System","○","Country-specific M&E &  Global AIDS Monitoring (GAM) guidelines, informed by the WHO guidelines (and PEPFAR, if applicable), are in place",null,null,null,null,{"$f":"IFERROR(O120,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L120:N128,\"<>0\",L120:N128),0),\"-\")","v":"-"}]
[null,null,null,"○","PrEP M&E incorporated into national HMIS (Electronic or paper based as available)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","HMIS allows for real time data collection",null,null,null,null,null,null,0,0,0]
[null,null,null,"○"," System in place for unique client IDs for those on PrEP, consistent with existing ID if available",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP providers trained on indicators and definitions",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Routine reporting is in place ",null,null,null,null,null,null,{"$f":"IF(ISBLANK(G125),0,1)","v":0},{"$f":"IF(ISBLANK(H125),0,3)","v":0},{"$f":"IF(ISBLANK(I125),0,5)","v":0}]
[null,null,null,"○","Data is disaggregated by gender, key population, and age (with smaller age bands for younger populations i.e. 15-19., 20-24, 25-29, etc)  and subnational level",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Data is used to monitor progress and inform financial and technical resource mobilization",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Progress is documented through a country level annual report",null,null,null,null,null,null,0,0,0]
[null,null,"Data flow","○","Clear reporting guidelines in place",null,null,null,null,{"$f":"IFERROR(O129,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L129:N139,\"<>0\",L129:N139),0),\"-\")","v":"-"}]
[null,null,null,"○","Clear flow of data from clinics > subnational > national level",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Regular review of data and feedback provided",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Data quality assessments are standardized,  take place regularly, and are used to address data issues",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","All stakeholders report into a single national system and data is harmonized",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","All implementers feed into the data system with accurate and timely data",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Accountability mechanisms directing data flow and ensuring quality data collection are in place and enforced               ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Data is disseminated down to subnational levels ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Implementers are capacitated to use data in decision-making ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Data is used to detect adverse events (AEs), assess the standard of care, measure progress toward achieving programme objectives,  and guide decision making",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Data is disseminated to the TWG in a timely manner",null,null,null,null,null,null,0,0,0]
[null,null,"Quality","○","Quality assessments take place regularly at the national and subnational levels",null,null,null,null,{"$f":"IFERROR(O140,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L140:N145,\"<>0\",L140:N145),0),\"-\")","v":"-"}]
[null,null,null,"○","Quality assessments are integrated into the broader health care system and include the traditional sector",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","All partners are compliant with global quality standards",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Quality assessments include several approaches: observation, interviews, focus group discussions, inventory checks, review of documents",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Findings from quality assessments are communicated to all stakeholders and appropriate action is enforced",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","There is support for quality improvement",null,null,null,null,null,null,0,0,0]
[null,null,"Pharmacovigilance","○","There are national definitions for the classification of AEs, which align to global standards",null,null,null,null,{"$f":"IFERROR(O146,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L146:N153,\"<>0\",L146:N153),0),\"-\")","v":"-"}]
[null,null,null,"○","Management of AEs is standardized across the programme ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","All stakeholders report on AEs on a defined regular basis",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","There is accurate reporting of AEs ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Patient feedback / follow-up takes place and is documented",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Patient referral processes are in place to link those that require additional care",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Resistance testing for people who seroconvert",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Periodic HIV drug resistance survey for PrEP users",null,null,null,null,null,null,0,0,0]
[]
[null,null,null,null,null,null,null,null,null,null,null,null,{"$f":"COUNTIF(O6:O153,\"-\")","v":22}]
[null,null,null,null,null,null,null,null,null,null,null,null,{"$f":"COUNTIF(O6:O153,\">0\")","v":0}]
[null,null,null,null,null,null,null,null,null,null,null,"Sheet Completion",{"$f":"M156/(M155+M156)","v":0},{"$f":"1-M157","v":1}]

{"sheet":"Programme Outcomes ","index":7,"n_rows":37,"n_cols":15,"rows_kept":37,"cut":false,"hidden":false,"merged":[[27,9,32,9],[1,2,1,8],[5,9,10,9],[11,9,15,9],[16,9,20,9],[21,9,26,9],[5,2,10,2],[11,2,15,2],[16,2,20,2],[21,2,26,2],[27,2,32,2]]}
[]
[null,null,"Programme Outcomes"]
[]
[null,null,"Element","Criteria",null,"N/A","Absent","Present but not optimal","Present and working well","Average for element","Comments (if applicable)","Absent","Present","Optimal","Average"]
[null,null,"Outcomes and indicators"]
[null,null,"PrEP uptake","○","PrEP uptake indicators for all available PrEP modalities (oral PrEP, ring, long-acting injectables) are in place",null,null,null,null,{"$f":"IFERROR(O6,\"-\")","v":"-"},null,{"$f":"IF(ISBLANK(G6),0,1)","v":0},{"$f":"IF(ISBLANK(H6),0,3)","v":0},{"$f":"IF(ISBLANK(I6),0,5)","v":0},{"$f":"IFERROR(ROUND(AVERAGEIF(L6:N11,\"<>0\",L6:N11),0),\"-\")","v":"-"}]
[null,null,null,"○","Indicators are defined as: % of eligible people who initiated [selected PrEP modality] during the reporting period                            ",null,null,null,null,null,null,{"$f":"IF(ISBLANK(G7),0,1)","v":0},{"$f":"IF(ISBLANK(H7),0,3)","v":0},{"$f":"IF(ISBLANK(I7),0,5)","v":0}]
[null,null,null,"○","PrEP uptake indicator data is collected quarterly",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Indicators for [selected PrEP modality] are disaggregated by gender, key population, geographic unit, and age (with smaller age bands for younger populations i.e. 15-19., 20-24, 25-29, etc)                                    ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Indicators for [selected PrEP modality] are disaggregated by first time and repeat PrEP users",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Nationally defined target (i.e. quarterly, annual) is met",null,null,null,null,null,null,0,0,0]
[null,null,"PrEP continuation","○","PrEP continuation indicators for all available PrEP modalities (oral PrEP, ring, long-acting injectables) are in place",null,null,null,null,{"$f":"IFERROR(O12,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L12:N16,\"<>0\",L12:N16),0),\"-\")","v":"-"}]
[null,null,null,"○","Indicators are defined as: % of [select PrEP modality] users who continued [selected PrEP modality] for 3 consecutive months after having initiated during the reporting period              ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP continuation indicator data is collected quarterly",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Indicators for [selected PrEP modality] are disaggregated by gender, key population, geographic unit, and age (with smaller age bands for younger populations i.e. 15-19., 20-24, 25-29, etc)                                       ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Nationally defined target (i.e. quarterly, annual) is met",null,null,null,null,null,null,0,0,0]
[null,null,"PrEP current","○","Currently on PrEP indicators for all available  PrEP modalities (oral PrEP, ring, long-acting injectables) are in place",null,null,null,null,{"$f":"IFERROR(O17,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L17:N21,\"<>0\",L17:N21),0),\"-\")","v":"-"}]
[null,null,null,"○","Indicators are defined as: number of people who received [select PrEP modality] at least once during the reporting period",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Currently on PrEP indicator data is collected quarterly",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Indicators for [selected PrEP modality] are disaggregated by gender, key population, geographic unit, and age (with smaller age bands for younger populations i.e. 15-19., 20-24, 25-29, etc)                                        age, sex, geographic unit and may be disaggregated by priority population",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Nationally defined target (i.e. quarterly, annual) is met",null,null,null,null,null,null,0,0,0]
[null,null,"Seroconversion among PrEP users","○","Indicators for seroconversion among PrEP users (for all available PrEP modalities) are in place",null,null,null,null,{"$f":"IFERROR(O22,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L22:N27,\"<>0\",L22:N27),0),\"-\")","v":"-"}]
[null,null,null,"○","Indicators are is clearly defined, including: separated by timing of seroconversion i.e. while on PrEP and after discontinuation",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Drug resistance among seroconverts is assessed",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","PrEP use history assessed among seroconverts              ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Indicators for [selected PrEP modality] are disaggregated by gender, key population, geographic unit, and age (with smaller age bands for younger populations i.e. 15-19., 20-24, 25-29, etc)                    Indicator is disaggregated by age, sex, geographical unit and may be disaggregated by priority population",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Nationally defined target (i.e. quarterly, annual) is met",null,null,null,null,null,null,0,0,0]
[null,null,"Programme effectiveness evaluated",null,"Effectiveness evaluation may include:",null,null,null,null,{"$f":"IFERROR(O28,\"-\")","v":"-"},null,0,0,0,{"$f":"IFERROR(ROUND(AVERAGEIF(L28:N33,\"<>0\",L28:N33),0),\"-\")","v":"-"}]
[null,null,null,"○","Evaluation includes Impact assessment (# HIV infections averted)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Evaluation includes Risk compensation indicator (STI surveillance) ",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Evaluation includes Collateral benefits indicator (# HIV+ identified through PrEP program)",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Evaluation is conducted routinely",null,null,null,null,null,null,0,0,0]
[null,null,null,"○","Program adapts to changes in HIV incidence and risk",null,null,null,null,null,null,0,0,0]
[null,null,null,null,null,null,null,null,null,null,null,null,null,0]
[null,null,null,null,null,null,null,null,null,null,null,null,{"$f":"COUNTIF(O6:O33,\"-\")","v":5}]
[null,null,null,null,null,null,null,null,null,null,null,null,{"$f":"COUNTIF(O6:O33,\">0\")","v":0}]
[null,null,null,null,null,null,null,null,null,null,null,"Sheet Completion",{"$f":"M36/(M35+M36)","v":0},{"$f":"1-M37","v":1}]

{"sheet":"Summary of scores","index":8,"n_rows":41,"n_cols":11,"rows_kept":41,"cut":false,"hidden":false,"merged":[[1,2,1,6],[2,3,4,3],[5,3,6,3],[2,2,7,2],[21,3,24,3],[8,2,28,2],[29,2,35,2],[25,3,28,3],[8,3,11,3],[12,3,14,3],[15,3,18,3],[19,3,20,3],[29,3,33,3]]}
[]
[null,null,"Summary of scores"]
[null,null,"Programme \nManagement","Strategy, policy, & regulation",null,"National HIV prevention strategy",{"$f":"'Programme Management'!O6","v":"-"}]
[null,null,null,null,null,"National Clinical Guidelines",{"$f":"'Programme Management'!O12","v":"-"}]
[null,null,null,null,null,"PrEP drug regulatory status",{"$f":"'Programme Management'!O21","v":"-"}]
[null,null,null,"Leadership & coordination",null,"Leadership & accountability",{"$f":"'Programme Management'!O25","v":"-"}]
[null,null,null,null,null,"Stakeholder engagement",{"$f":"'Programme Management'!O28","v":"-"}]
[null,null,null,"Financing",null,"Budget",{"$f":"'Programme Management'!O35","v":"-"}]
[null,null,"Programme Implementation","Targeting & planning",null,"Implementation work plans",{"$f":"'Programme Implementation'!O6","v":"-"}]
[null,null,null,null,null,"Assessment of population at risk",{"$f":"'Programme Implementation'!O13","v":"-"}]
[null,null,null,null,null,"Indicator targets",{"$f":"'Programme Implementation'!O18","v":"-"}]
[null,null,null,null,null,"Communication strategy",{"$f":"'Programme Implementation'!O27","v":"-"}]
[null,null,null,"Supply",null,"Quantification of commodities need",{"$f":"'Programme Implementation'!O36","v":"-"}]
[null,null,null,null,null,"Commodity procurement plan",{"$f":"'Programme Implementation'!O40","v":"-"}]
[null,null,null,null,null,"Supply chain/LMIS",{"$f":"'Programme Implementation'!O45","v":"-"}]
[null,null,null,"Service delivery",null,"Differentiated",{"$f":"'Programme Implementation'!O54","v":"-"}]
[null,null,null,null,null,"Integrated",{"$f":"'Programme Implementation'!O58","v":"-"}]
[null,null,null,null,null,"Accessible",{"$f":"'Programme Implementation'!O64","v":"-"}]
[null,null,null,null,null,"Acceptable",{"$f":"'Programme Implementation'!O68","v":"-"}]
[null,null,null,"Service delivery support",null,"Training",{"$f":"'Programme Implementation'!O72","v":"-"}]
[null,null,null,null,null,"Service Delivery Tools      ",{"$f":"'Programme Implementation'!O78","v":"-"}]
[null,null,null,"Clinical services package",null,"Eligibility and initiation testing",{"$f":"'Programme Implementation'!O81","v":"-"}]
[null,null,null,null,null,"Clinical follow up",{"$f":"'Programme Implementation'!O92","v":"-"}]
[null,null,null,null,null,"Counselling and effective use support",{"$f":"'Programme Implementation'!O101","v":"-"}]
[null,null,null,null,null,"PrEP adjacent package",{"$f":"'Programme Implementation'!O111","v":"-"}]
[null,null,null,"Programme monitoring",null,"PrEP M&E system",{"$f":"'Programme Implementation'!O120","v":"-"}]
[null,null,null,null,null,"Data flow",{"$f":"'Programme Implementation'!O129","v":"-"}]
[null,null,null,null,null,"Quality",{"$f":"'Programme Implementation'!O140","v":"-"}]
[null,null,null,null,null,"Pharmacovigilance",{"$f":"'Programme Implementation'!O146","v":"-"}]
[null,null,"Programme Outcomes","Outcomes & indicators",null,"PrEP uptake",{"$f":"'Programme Outcomes '!O6","v":"-"}]
[null,null,null,"6. Differentiated service delivery",null,"PrEP continuation",{"$f":"'Programme Outcomes '!O12","v":"-"}]
[null,null,null,null,null,"PrEP Current",{"$f":"'Programme Outcomes '!O17","v":"-"}]
[null,null,null,null,null,"Seroconversion among PrEP users",{"$f":"'Programme Outcomes '!O22","v":"-"}]
[null,null,null,null,null,"Program effectiveness evaluated",{"$f":"'Programme Outcomes '!O28","v":"-"}]
[null,null,null,"Sustainability indicators",null,null,{"$f":"IFERROR(ROUND(AVERAGE('Programme Management'!P6:P83),0),\"-\")","v":"-"}]
[null,null,null,"COVID-19 (and other pandemics) indicators",null,null,{"$f":"IF((SUM('Programme Management'!L20:N20)+SUM('Programme Implementation'!L117:N117)+SUM('Programme Implementation'!L118:N118))/3=0,\"-\", ROUND((SUM('Programme Management'!L20:N20)+SUM('Programme Implementation'!L117:N117)+SUM('Programme Implementation'!L118:N118))/3,0))","v":"-"}]
[]
[]
[null,null,null,null,null,null,null,null,null,{"$f":"COUNTIF(G3:G36,\"-\")","v":34}]
[null,null,null,null,null,null,null,null,null,{"$f":"COUNTIF(G3:G36,\">0\")","v":0}]
[null,null,null,null,null,null,null,null,"PSAT Completion",{"$f":"J40/(J39+J40)","v":0},{"$f":"1-J41","v":1}]

{"sheet":"Next steps","index":9,"n_rows":54,"n_cols":8,"rows_kept":54,"cut":false,"hidden":false,"merged":[[1,2,1,8],[11,2,11,3]]}
[]
[null,null,"Next Steps"]
[]
[null,null,null,null,null,"Element that needs to be addressed","Reason for low performance","Proposed actions (e.g. support required or corrective actions)."]
[null,null,null,null,1,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(3:3))),\"\")","v":0}]
[null,null,null,null,2,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(4:4))),\"\")","v":0}]
[null,null,null,null,3,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(5:5))),\"\")","v":0}]
[null,null,null,null,4,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(6:6))),\"\")","v":0}]
[null,null,null,null,5,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(7:7))),\"\")","v":0}]
[null,null,null,null,6,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(8:8))),\"\")","v":0}]
[null,null,null,null,7,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(9:9))),\"\")","v":0}]
[null,null,null,null,8,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(10:10))),\"\")","v":0}]
[null,null,null,null,9,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(11:11))),\"\")","v":0}]
[null,null,null,null,10,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(12:12))),\"\")","v":0}]
[null,null,null,null,11,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(13:13))),\"\")","v":0}]
[null,null,null,null,12,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(14:14))),\"\")","v":0}]
[null,null,null,null,13,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(15:15))),\"\")","v":0}]
[null,null,null,null,14,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(16:16))),\"\")","v":0}]
[null,null,null,null,15,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(17:17))),\"\")","v":0}]
[null,null,null,null,16,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(18:18))),\"\")","v":0}]
[null,null,null,null,17,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(19:19))),\"\")","v":0}]
[null,null,null,null,18,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(20:20))),\"\")","v":0}]
[null,null,null,null,19,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(21:21))),\"\")","v":0}]
[null,null,null,null,20,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(22:22))),\"\")","v":0}]
[null,null,null,null,21,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(23:23))),\"\")","v":0}]
[null,null,null,null,22,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(24:24))),\"\")","v":0}]
[null,null,null,null,23,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(25:25))),\"\")","v":0}]
[null,null,null,null,24,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(26:26))),\"\")","v":0}]
[null,null,null,null,25,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(27:27))),\"\")","v":0}]
[null,null,null,null,26,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(28:28))),\"\")","v":0}]
[null,null,null,null,27,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(29:29))),\"\")","v":0}]
[null,null,null,null,28,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(30:30))),\"\")","v":0}]
[null,null,null,null,29,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(31:31))),\"\")","v":0}]
[null,null,null,null,30,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(32:32))),\"\")","v":0}]
[null,null,null,null,31,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(33:33))),\"\")","v":0}]
[null,null,null,null,32,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(34:34))),\"\")","v":0}]
[null,null,null,null,33,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(35:35))),\"\")","v":0}]
[null,null,null,null,34,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(36:36))),\"\")","v":0}]
[null,null,null,null,35,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(37:37))),\"\")","v":0}]
[null,null,null,null,36,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(38:38))),\"\")","v":0}]
[null,null,null,null,37,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(39:39))),\"\")","v":0}]
[null,null,null,null,38,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(40:40))),\"\")","v":0}]
[null,null,null,null,39,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(41:41))),\"\")","v":0}]
[null,null,null,null,40,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(42:42))),\"\")","v":0}]
[null,null,null,null,41,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(43:43))),\"\")","v":0}]
[null,null,null,null,42,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(44:44))),\"\")","v":0}]
[null,null,null,null,43,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(45:45))),\"\")","v":0}]
[null,null,null,null,44,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(46:46))),\"\")","v":0}]
[null,null,null,null,45,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(47:47))),\"\")","v":0}]
[null,null,null,null,46,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(48:48))),\"\")","v":0}]
[null,null,null,null,47,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(49:49))),\"\")","v":0}]
[null,null,null,null,48,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(50:50))),\"\")","v":0}]
[null,null,null,null,49,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(51:51))),\"\")","v":0}]
[null,null,null,null,50,{"$f":"IFERROR(INDEX('Summary of scores'!$F$1:$F$93,SMALL(IF('Summary of scores'!$G$1:$G$93<=$C$12,ROW('Summary of scores'!$G$1:$G$93)),ROW(52:52))),\"\")","v":0}]

{"sheet":"Bibliography","index":10,"n_rows":29,"n_cols":4,"rows_kept":29,"cut":false,"hidden":false,"merged":[[1,2,1,3]]}
[]
[null,null,"Bibliography"]
[null,null,1,"CDC (2017). PrEP Guidelines: CDC provider supplement"]
[null,null,2,"WHO (2016).Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection"]
[null,null,3,"WHO (2017). Implementation tool for pre-exposure prophylaxis of HIV infection"]
[null,null,4,"OPTIONS (2019). Provider training package: Effective delivery of oral PrEP for adolescent girls and young women"]
[null,null,5,"OPTIONS (2019). PrEP-it tool"]
[null,null,6,"WHO (2016). Recommendations for a public health approach - Second edition"]
[null,null,7,"UNAIDS (2017). HIV Prevention 2020 Road Map"]
[null,null,8,"USAID (2005). Guidelines for managing HIV supply chain"]
[null,null,9,"WHO (2015). WHO good distribution practices for pharmaceutical products"]
[null,null,10,"WHO (2017). WHO implementation tool for pre-exposure prophylaxis of HIV infection"]
[null,null,11,"WHO (2019) What’s the 2+1+1? Event-driven oral pre-exposure prophylaxis to prevent HIV for men who have sex with men: Update to WHO’s recommendation on oral PrEP"]
[null,null,12,"WHO (2021) Updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring"]
[null,null,13,"WHO (2020) HIV drug resistance surveillance in countries scaling up pre-exposure prophylaxis"]
[null,null,14,"WHO (2020) Consolidated HIV strategic information guidelines: driving impact through programme monitoring and management"]
[null,null,15,"PEPFAR (2020) Monitoring, Evaluation, and Reporting Indicator Reference Guide - MER 2.0 (Version 2.5)"]
[null,null,16,"WHO (2019) Prevention and control of sexually transmitted infections (STIs) in the era of oral pre-exposure prophylaxis (PrEP) for HIV"]
[null,null,17,"UNAIDS End Inequalities. End AIDS. Global AIDS Strategy 2021-2026"]
[null,null,18,"WHO (2018) Implementation tool for pre-exposure prophylaxis (PrEP) of HIV infection. Module 12: Adolescents and young adults"]
[null,null,19,"PrEP Learning Network (2019) Target setting for PrEP "]
[null,null,20,"UNAIDS (2019) Scorecards and Country Posters in the Global HIV Prevention Coalition"]
[null,null,21,"Joint United Nations Programme on HIV/AIDS. (2020). Maintaining and prioritizing HIV prevention services in the time of COVID-19."]
[null,null,22,"Joint United Nations Programme on HIV/AIDS. (2020). Condoms and lubricants in the time of COVID-19. Sustaining supplies and people-centred approaches to meet the need in low- and middle-income countries."]
[null,null,23,"Joint United Nations Programme on HIV/AIDS. (2020). UNAIDS highlights six critical actions to put gender equality at the centre of COVID-19 responses. "]
[null,null,24,"Joint United Nations Programme on HIV/AIDS. (2020). Strategic Considerations for Mitigating the Impact of COVID-19 on Key-Population-Focused HIV Programs."]
[null,null,25,"Joint United Nations Programme on HIV/AIDS. (2020). Preventing HIV and other STIs among women and girls using contraceptive services in contexts with high HIV incidence. "]
[null,null,26,"Joint United Nations Programme on HIV/AIDS. (2021). Going Online: A Budgeting and Programming Aid for Virtual HIV Interventions. "]
[null,null,27,"UNAIDS. (2019) Global HIV Prevention Coalition prevention scorecards and posters"]

{"sheet":"Acronyms","index":11,"n_rows":39,"n_cols":4,"rows_kept":39,"cut":false,"hidden":false,"merged":[[1,2,1,8]]}
[]
[null,null,"Acronyms"]
[]
[null,null,"AE","Adverse event"]
[null,null,"AGYW","Adolescent girls and young women "]
[null,null,"ANC","Antenatal care"]
[null,null,"ART","Antiretroviral therapy"]
[null,null,"ARV","Antiretroviral drugs"]
[null,null,"CrCl","Creatine clearance test"]
[null,null,"DVR","Dapivirine Vaginal Ring"]
[null,null,"EML","Essential Medicines List"]
[null,null,"FP","Family planning"]
[null,null,"FSW","Female Sex Worker"]
[null,null,"HBV","Hepatitis B virus "]
[null,null,"HCT","HIV counselling and testing"]
[null,null,"HCV","Hepatitis C virus "]
[null,null,"HMIS","Health management information system"]
[null,null,"HR","Human resources"]
[null,null,"KP","Key populations "]
[null,null,"LMIS","Logistics management information system"]
[null,null,"M&E","Monitoring and evaluation"]
[null,null,"MSM","Men who have sex with men "]
[null,null,"NSP","National Strategic Plan"]
[null,null,"PEPFAR","President's Emergency Plan for AIDS Relief"]
[null,null,"PLHIV","People living with HIV"]
[null,null,"PNC","Prenatal care"]
[null,null,"PrEP","Pre-exposure prophylaxis"]
[null,null,"PSAT","Prevention Self-Assessment Tool"]
[null,null,"SAE","Severe adverse event "]
[null,null,"SRH","Sexual and reproductive health"]
[null,null,"STI ","Sexually transmitted infection"]
[null,null,"TA","Technical assistance plan"]
[null,null,"TOR","Terms of reference"]
[null,null,"TWG","Technical working group "]
[null,null,"UNAIDS","Joint United Nations Programme on HIV/AIDS "]
[null,null,"USAID","United States Agency for International Development"]
[null,null,"VL","Viral load"]
[null,null,"VMMC","Voluntary medical male circumcision"]
[null,null,"WHO","World Health Organization "]